Vigabatrin And Visual Field Loss In Children.: Revision history

27 June 2024

• curprev 21:0421:04, 27 June 2024‎ EmeliaMarrufo talk contribs‎ m 1,333 bytes −164‎ No edit summary undo
• curprev 19:2819:28, 27 June 2024‎ DarellHeaton talk contribs‎ m 1,497 bytes +137‎ No edit summary undo
• curprev 18:2318:23, 27 June 2024‎ JennieLhq598281 talk contribs‎ m 1,360 bytes −47‎ No edit summary undo

10 June 2024

• curprev 23:1223:12, 10 June 2024‎ HueyFullarton talk contribs‎ m 1,407 bytes +28‎ No edit summary undo
• curprev 23:0923:09, 10 June 2024‎ TeodoroWaldman talk contribs‎ m 1,379 bytes +56‎ No edit summary undo
• curprev 22:5122:51, 10 June 2024‎ NancyBronson talk contribs‎ m 1,323 bytes −120‎ No edit summary undo
• curprev 19:2519:25, 10 June 2024‎ TrudyPhifer29 talk contribs‎ m 1,443 bytes +25‎ No edit summary undo
• curprev 18:4718:47, 10 June 2024‎ CarmellaNave talk contribs‎ m 1,418 bytes +11‎ No edit summary undo

9 June 2024

• curprev 09:2309:23, 9 June 2024‎ AugustJoiner0 talk contribs‎ 1,407 bytes +1,407‎ Created page with "Before starting SABRIL, inform your physician regarding all of your (or your youngster's) clinical conditions including clinical depression, state of mind problems, self-destructive thoughts [https://atavi.com/share/womnm3z6brgo vigabatrin ocular side effects] or actions, any type of allergic reaction to SABRIL, vision troubles, kidney problems, reduced red cell matters (anemia), and any type of mental or nervous disease.<br><br>The Vigabatrin REMS Program is required by..."